Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?

To: ghmm who wrote (378)	2/26/2013 1:59:31 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 507

Has been a strange day of trading---moved up and then down, but as I write it is now above morning level and volume seems to be building. Chart is looking good for a breakout--but the $9.50 level seems to be the resistance level--so we need to break above $9.50 on improving volume. Q conference call coming up on Thursday should be interesting! Fingers are crossed! Put your radar on CLDX----I started buy recently at the low $8.00 level. I finished my allocation to a particular stock by buying this morning @$9.08 level. Put down on your calendar for upcoming Q call----they promise an update on one of their drug candidates. They recently did a secondary offering---and the stock deal a rarity........it went up above the secondary offering price, when normally a stock trades down on secondary offerings. I believe that there is going to be more consolidation in the pharma arena--CLDX would be a prime candidate(IMO)